前收盘价格 | 0.914 |
收盘价格 | 0.920 |
成交量 | 10,043,612 |
平均成交量 (3个月) | 4,042,074 |
市值 | 271,822,464 |
价格/销量 (P/S) | 51.13 |
股市价格/股市净资产 (P/B) | 7.52 |
52周波幅 | |
利润日期 | 6 Aug 2025 - 11 Aug 2025 |
营业利益率 (TTM) | -1,811.52% |
稀释每股收益 (EPS TTM) | -0.200 |
季度收入增长率 (YOY) | -45.80% |
总债务/股东权益 (D/E MRQ) | 109.69% |
流动比率 (MRQ) | 2.86 |
营业现金流 (OCF TTM) | -42.14 M |
杠杆自由现金流 (LFCF TTM) | -24.64 M |
资产报酬率 (ROA TTM) | -46.57% |
股东权益报酬率 (ROE TTM) | -154.01% |
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 看跌 | 看跌 |
Biotechnology (全球的) | 看跌 | 看跌 | |
股票 | Ocugen, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
分析师共识 | 1.5 |
内部交易活动 | NA |
价格波动 | 2.0 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 2.0 |
平均 | 1.38 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA"). |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Core |
内部持股比例 | 1.27% |
机构持股比例 | 24.75% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Gmt Capital Corp | 31 Mar 2025 | 4,153,798 |
Rinkey Investments | 31 Mar 2025 | 1,164,506 |
52周波幅 | ||
目标价格波幅 | ||
高 | 7.00 (HC Wainwright & Co., 652.04%) | 购买 |
7.00 (Chardan Capital, 652.04%) | 购买 | |
中 | 7.00 (652.04%) | |
平均值 | 7.00 (652.04%) | |
总计 | 2 购买 | |
平均价格@调整类型 | 0.700 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Chardan Capital | 12 May 2025 | 7.00 (652.04%) | 购买 | 0.700 |
06 Mar 2025 | 7.00 (652.04%) | 购买 | 0.631 | |
HC Wainwright & Co. | 12 May 2025 | 7.00 (652.04%) | 购买 | 0.700 |
06 Mar 2025 | 8.00 (759.48%) | 购买 | 0.631 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合